Diagnostic Imaging Approaches to Prostate Cancer

Edouard J Trabulsi, Leonard G Gomella
2007 European Oncology & Haematology  
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death in American men, with an estimated 186,320 new cases diagnosed and 28,660 prostate cancer deaths expected in the US in 2008. 1 With the use of prostate-specific antigen (PSA)-based screening, the number of prostate biopsies performed to diagnose prostate cancer has risen sharply over the past two decades, with a majority of those biopsies being negative. 2 Conversely, the falsenegative rate of
more » ... egative rate of standard transrectal ultrasound (TRUS)-guided prostate biopsy is significant, approaching 30-40%. 3 Additionally, the clinical significance of low-volume, low-grade prostate cancer detected on needle biopsy is unclear. The controversy regarding the potential Diagnostic Imaging Approaches to Prostate Cancer
doi:10.17925/eoh.2007.0.2.110 fatcat:2mphi4nswveldf4u72krqikgzm